Tan YN - Search Results

1

Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer.

Zhang Y, Zhang TT, Gao L, Tan YN, Li YT, Tan XY, Huang TX, Li HH, Bai F, Zou C, Pei XH, Tan BB, Fu L. Zhang Y, et al. Among authors: tan yn. Int J Biol Sci. 2022 Apr 24;18(7):3034-3047. doi: 10.7150/ijbs.67149. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541910 Free PMC article.

2

Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors.

Tan YN, Huang JD, Li YP, Li SS, Luo M, Luo J, Lee AW, Fu L, Hu FQ, Guan XY. Tan YN, et al. Adv Healthc Mater. 2022 Mar;11(6):e2101496. doi: 10.1002/adhm.202101496. Epub 2021 Dec 17. Adv Healthc Mater. 2022. PMID: 34878725

3

Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer.

Li Y, Tan Y, Wen L, Xing Z, Wang C, Zhang L, Wu K, Sun H, Li Y, Lei Q, Wu S. Li Y, et al. Mol Ther Nucleic Acids. 2021 Sep 28;26:798-812. doi: 10.1016/j.omtn.2021.09.011. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34729249 Free PMC article.

4

Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.

Zhao Y, Tan Y, Meng T, Liu X, Zhu Y, Hong Y, Yang X, Yuan H, Huang X, Hu F. Zhao Y, et al. Drug Deliv. 2018 Nov;25(1):341-352. doi: 10.1080/10717544.2018.1425778. Drug Deliv. 2018. PMID: 29355035 Free PMC article.

5

Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells.

Zhu Y, Yu F, Tan Y, Hong Y, Meng T, Liu Y, Dai S, Qiu G, Yuan H, Hu F. Zhu Y, et al. Theranostics. 2019 Sep 19;9(23):6764-6779. doi: 10.7150/thno.36334. eCollection 2019. Theranostics. 2019. PMID: 31660067 Free PMC article.

6

Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor.

Tan YN, Li YP, Huang JD, Luo M, Li SS, Lee AW, Hu FQ, Guan XY. Tan YN, et al. Cancer Lett. 2021 Dec 1;522:238-254. doi: 10.1016/j.canlet.2021.09.031. Epub 2021 Sep 24. Cancer Lett. 2021. PMID: 34571084

7

Guiding Appropriate Timing of Laser Irradiation by Polymeric Micelles for Maximizing Chemo-Photodynamic Therapy.

Zhu Y, Yu F, Tan Y, Wen L, Li Y, Yuan H, Hu F. Zhu Y, et al. Int J Nanomedicine. 2020 Aug 31;15:6531-6543. doi: 10.2147/IJN.S256477. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32982216 Free PMC article.

8

AKT activation by SC79 to transiently re-open pathological blood brain barrier for improved functionalized nanoparticles therapy of glioblastoma.

Wen L, Wang K, Zhang F, Tan Y, Shang X, Zhu Y, Zhou X, Yuan H, Hu F. Wen L, et al. Biomaterials. 2020 Apr;237:119793. doi: 10.1016/j.biomaterials.2020.119793. Epub 2020 Jan 20. Biomaterials. 2020. PMID: 32044521

9

Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy.

Wen L, Hu Y, Meng T, Tan Y, Zhao M, Dai S, Yuan H, Hu F. Wen L, et al. Colloids Surf B Biointerfaces. 2019 Mar 1;175:392-402. doi: 10.1016/j.colsurfb.2018.12.016. Epub 2018 Dec 7. Colloids Surf B Biointerfaces. 2019. PMID: 30554018

10

VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.

Wen L, Tan Y, Dai S, Zhu Y, Meng T, Yang X, Liu Y, Liu X, Yuan H, Hu F. Wen L, et al. Drug Deliv. 2017 Nov;24(1):1843-1855. doi: 10.1080/10717544.2017.1386731. Drug Deliv. 2017. PMID: 29182025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters